"GET SMARTER ABOUT CANCER" - Lecture Series- feat. Dr. Joshua Berka

FOREWORD
By: DR ROBERT L. BARD, Cancer Diagnostic Imaging Specialist

For the many Americans who seek a significantly improved lifestyle or an upgrade in personalized healthcare, getting better answers about our state of health is paramount. What goes into our "standard of care" is no longer acceptable to the the vast majority of general consumer. These same consumers have since been educated in what's available as far as intelligent alternative modalities from highly qualified and educated professionals that have proven wellness success in their respective specialty practices. The visionary paradigm that makes up FUNCTIONAL MEDICINE is defined as individualized medical care that recognizes the interactions between genetic and environmental factors and between the body's interconnected systems. True personalized care is patient-centered care. Subscribing to a FUNCTIONAL TESTING, MONITORING AND DIAGNOSTIC STRATEGY offers the ideal launch pad to a platform of true wellness and disease prevention.  It is for this innovative minset to problem-solving that we are proud to welcome Dr. Joshua Berka as one of the "Get Smarter about Cancer" lecture series. 

Dr. Berka is double board-certified and licensed Naturopathic Doctor (ND) and Acupuncturist (L.Ac.) as well a Certified Functional Medicine Practitioner (FMCP). He is passionate about Integrative, Preventative, Functional and Regenerative Medicine and is an advocate for personalized patient-centered care. Dr. Berka has been in clinical practice for 17 years and serves as a medical consultant supporting innovative medical technologies that non-invasively improve patient treatment outcomes as well as adjunctive therapeutics that can be used as a part of a healthy lifestyle. Dr. Berka has been a consultant within the med-tech space for the past 15 years and currently consults for BEMER Group (news source- Medium.com)

DIRECT FROM THE INTERVIEW
transcript by: Dr. Joshua Berka (10/25/2024)

I had the opportunity to work in the integrated field when I was in Los Angeles for over seven years, and to integrate the field of in integrative oncology. I trained more naturopathically functionally. Before we can get into the recurrence aspect, we have to look at the manifestation of this. Sure, we all have cancer in our body, but why this person expresses versus the next person, (and it's not just the genes), it's how those genes are being expressed. And so many cases exist within women's cancers -especially breast cancer. A lot of this is not just from the genetics- this is only one piece of this. 

Another factor is that the victim maybe not able to circulate or clear out metabolic waste products. Our estrogens (both men and women) are broken up, built up and they're all built from cholesterol.  And those metabolites can be sometimes a hundred times more toxic than the estrogens themselves. If that individual doesn't have the detox capacities, and then they're overwhelmed with, for instance, things within their environment, this sets up the perfect storm for that individual to have the (gene) expression. 

I don't care if they're treated with conventional chemotherapy radiation; the root cause has not been addressed. And in this particular case, it's a hetero or a homozygous type of situation where they can be supportive in their ability to metabolize and clear those detrimental waste products, those metabolic waste products. So it might basically be something that is supporting the gene expression for a little gap versus thinking that cancer is here. 

Let's use a targeted therapy (which is not really targeted in many cases) to take out that which is a disease. And from my perspective, I want to talk about cancer. As far as solid tumors (as opposed to lymphomas, leukemias and the like)- every time I have looked under my microscope looking at cancer or looking at measurements like Dr. Bard is doing, he's really looking functionally with ultrasound in real time during therapeutic interventions. I've done a lot of the same over the years and what I found, (without a doubt) is carcinogenic tissue is not functioning at the same level of energy production. 

So back to bioenergetics mitochondria as healthy tissue, maybe we can envision it this way. This is how stem cells used to be replicated. Imagine, I mean, it's the season, it's the fall. All the trees are dropping their leaves and pine cones are dropping.  They're doing this because winter is coming and that species and that grouping may not make it through another winter. So in hopes of survival.  It's actually seeding its environment. If you take energy or you take a cell out of the body and you expose it to an environment that doesn't have fluid (dry), one of the first things it starts to do before it apoptosis is it actually starts to replicate. It differentiates into an embryological state and then starts to replicate. These cells are not necessarily functional, but it's a response/reaction to these environmental signaling.  When treating individuals with cancer (not treating cancer) my primary goal is to target the mitochondrial bioenergetics and the functional utilization and transformation of energy with an individual. 

Courtesy of Aspen Laser

And many times those tumors will actually apoptose on their own once you start raising the energy around it. What types of medical devices do this?  Diet, food, positive thinking, neutral thinking. Lasers directly can input PHOTOBIOMODULATION photons into electron raising the electron transport chain to raise the zeta potential of erythrocyte or the outside membrane potential of a cell pulse. 

ELECTROMAGNETIC field therapy can also wirelessly inductively charge up these cells. So I think down the road, we have to rather look beyond a "kill, kill, kill" concept with these cells, and reintegrate  and reprogram those cells back into the system.  

What I was doing (research) was homing stem cells, enacting programming information into cells, not just with wireless signals but also with PEPTIDES. You don't need a viral vector to deliver that. You can actually deliver the signal in many ways, wirelessly or through aspects of light.    --- To be continued---

Video News Release: Innovations in Early Detection "Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection.  This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms.

PREDISPOSITION
So when I look at the predisposition of an individual, I don't just look at it from a structural perspective. There's the mental/emotional aspects, socioeconomics- and even down to a spiritual aspects. Unfortunately (or fortunately in some ways), these predispositions aren't just inherited on a genetic level. They're actually learned behaviors that we've observed from people who are close to us.  But we've perceived as close who are around us, and "living styles" and habits- ways that we've learned to cope with stress in either a functional way or in a dysfunctional way. And so, when I look at this predisposition, it's a combination of elements- and not just "that's my parents' fault... these are the genes I got!". Unfortunately, that game's NOT TRUE. This it's a bit of 'MYTHinformation' because yes, you do have the propensity to express in a certain way, but not necessarily the predisposition. 

That predisposition is a series of events or decisions that are made to allow that to be expressed. So why some people smoke their whole life and they don't get cancer, well is because they're not predisposed for that in essence.  The predisposition of each individual needs to be really looked at on a personalized level of uniqueness-- what I just call PERSONALIZED PATIENT CENTERED MEDICINE. Rather than saying "here's the disease", let's find out exactly how you got it.  It's important to find out the ideology of the cause, but it's more important to talk about RECURRENCE to prevent something that's occurred, even though when it was perceptually treated.  

We can identify our predispositions or possibilities of (gene) expression of both health or disease by looking at the parents and you could say, oh, this person died of heart disease or ovarian cancer.  But more so with early diagnostics, you can start looking at not just the genomic profiles, but you can start looking at functional diagnostics at a level of blood testing or saliva testing, looking at adrenal function, even looking at bits of certain types of carcinogenic DNA that's floating through the blood. From that perspective of predisposition, we can PREDICT nature. Once you know the predisposition of an individual, then you can predict the potential outcome. 

It's going to be harsh for a lot of the doctors out there and is something that I've observed. (If you can prove me wrong, I ask you, please do so). This aspect of ANABOLIC versus CATABOLIC metabolism. Generally, cancer patients with a solid state tumor status are in a SYSTEMIC aspect of anabolic metabolism. 

They're kind of stuck. #1: Cancer is a tumor, but it's a systemic disease. We have to understand this. #2: Cardiovascular disease or heart disease is more of a catabolic type of disease. So catabolic versus anabolic. I want to know if there's anybody who has ever seen cancer and heart disease happening simultaneously other than prostate cancer. This is a call out to the world. And I'm asking this because if we can just look at fundamental, basic anabolic catabolic cycles.  We may be able to push these metabolic cycles- not just through diet, sleep & wake cycles, but also lifestyle medicine. 

Most of lifestyle medicine is free. It doesn't cost a penny. 

---

Saturday, September 21, 2024

RECURRRENCE EXPLAINED

ADVOCACY & JOINING HANDS TO MAKE A DIFFERENCE

By: Geri Barish -  Hewlett House (Cancer Resource)

Getting the word out is vital when it comes to supporting our community in the fight against cancer.  Part of the search for answers is learning how to assess your own life - including your history, the area where you live, what you eat, what you breathe and your genetic blueprint. This may lead to identifying any kind of cancer in the family.  

Staying vigilant in understanding how cancer happens and how it affects us and our families is the key to awareness. Advocacy is also about supporting one another. As we wait for the cure, we also need to live a full life- this includes staying proactive with our health and staying in touch with the latest solutions. There's a lot more work to be done- and because we are fighters, we have to keep asking questions. Look at your environment- get genetic testing for gene mutation in your lineage, don't ignore checkups- find out if you have any risk factors. That's where education and research comes together. And if you've had cancer already, please don't think it won't come back. Recurrence (or re-occurrence) is a real term- and when it happens, it can come back with a vengeance. 

There is a constant debate in the cancer community about the term "CANCER FREE". Cancer recurrence continues to be a major concern as reported in annual medical reports- identifying its tendency to “return with a vengeance". [1, 2]

Medical research has identified the major reasons why cancer recurs.  A widely reported cause for this is attributed to a deficiency in treatment performance. [2] This means the therapy induced did not successfully remove or kill all of the cancer cells, possibly due to the patient's level of drug resistance.  During treatment, Cancer cells can enter a dormant state to protect themselves from treatment and other stimuli. Over time, these dormant cells can reactivate. The cause of this may be a spike in chronic stress or the release of toxins from oxidative stress from environmental factors like smoking or repeat exposure to reactive chemicals. [3]

Inflammation has also been linked to the activation of immune cells called neutrophils. [4] Cancer cells that have spread to other areas of the body after successful treatment of the original tumor can remain dormant for years or decades before recurring as metastatic cancer. Further activators of these dormant cells have also been linked to one's personal Epigenetics. [5] This determines how your environment and lifestyle affects your cell function- including the dormancy state of your cancer cells. 

Another known cause for recurrence are Cancer stem cells or CSC's.  These are a small group of cells in tumors that have the ability to self-renew, differentiate, and give rise to all cell types in a tumor. [6] Most stages of tumor progression, including tumorigenesis, promotion, progression, and recurrence are accompanied by epigenetic alterations, some of which can be reversed by epigenetic drugs. [6]

DETECTION MONITORING

After cancer surgery, there are many preventive measures to support a safe and healthy recovery and to reduce the risk of recurrence.  A logical and preventive strategy as part of postop maintenance is called RECURRENCE PREVENTION SCANS. Through the use of affordable, real-time medical imaging such as the 3D Doppler Ultrasound, post-cancer surgery patients can subscribe to a personal monitoring regimen to scan for any potential lesions and micro-tumors that may have fallen under the radar.  Proactive monitoring can also address complications such as post-surgical Infections, recurring pain, swelling, neuropathy from nerve damage, scarring, fluid buildup or blood clots. In less than 20 minutes per visit, you earn peace of mind from a comprehensive scan by seasoned specialists trained to support postop patient management.

(1) Butow P, Sharpe L, Thewes B, et al. Fear of Cancer Recurrence: A Practical Guide for Clinicians. Oncology (Williston Park). 2018 Jan 15;32(1):32-8. (2.) Mahvi DA, Liu R, Grinstaff MW, et al. (2018). Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. CA: A Cancer Journal for Clinicians, 68(6), 488. https://doi.org/10.3322/caac.21498 (3.)Payne KK. Cellular stress responses and metabolic reprogramming in cancer progression and dormancy. Seminars in cancer biology 2022 Jan Vol. 78, pp. 45-48. (4.) He X-Y, Gao Y, Ng D et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell 2024:42(3);474-486. DOI: https://doi.org/10.1016/j.ccell.2024.01.013  (5.) Costa S, Alves Sales SL, Pinheiro DP, et al. (2023). Epigenetic reprogramming in cancer: From diagnosis to treatment. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1116805 (6.) aYu X, Zhao H, Wang R, et al. (2024). Cancer epigenetics: From laboratory studies and clinical trials to precision medicine. Cell Death Discovery, 10(1), 1-12. https://doi.org/10.1038/s41420-024-01803-z

ROBERT L. BARD, MD  (Diagnostic Imaging Specialist)

Having paved the way for the study of various cancers both clinically and academically, Dr. Robert Bard co-founded the 9/11 CancerScan program to bring additional diagnostic support to all first responders from Ground Zero. His main practice in midtown, NYC (Bard Diagnostic Imaging- www.CancerScan.com) uses the latest in digital Imaging technology has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. His most recent program is dedicated to the reporting of mental health diagnostic and innovative solutions including the use of modern neuromagnetic technologies and protocols in his MEDTECH REVIEWS program. www.BardDiagnostics.com

ROBERTA KLINE, MD (Educational Dir. /Women's Diagnostic Group)

Dr. Kline is a board-certified ObGyn physician, Integrative Personalized Medicine expert, consultant, author, and educator whose mission is to change how we approach health and deliver healthcare. She helped to create the Integrative & Functional Medicine program for a family practice residency, has consulted with Sodexo to implement the first personalized nutrition menu for healthcare facilities, and serves as Education Director for several organizations including the Women’s Diagnostic Health Network, Mommies on a Mission. Learn more at https://bobbiklinemd.com 

---

HealthTech Reporter and Fight Recurrence brings you the conclusion of JIM HUNT's 6-Year personal journey report about his battle against early Prostate Cancer.  After years of ACTIVE SURVEILLANCE, a recent uptick in tumor size (5mm) was time enough to "do something more proactive about my cancer!".  Jim has been a prominent researcher on the topic of cancer care since his wife survived breast cancer 20 years ago. Today, his exploration led him to recognize the benefits of non-invasive cancer treatments including the advancements of radiation therapy such as PROTON BEAM therapy. (See his mini-documentary video: DAY 5/ Final Treatment day)